Study of Maggot Therapy in Diabetic Foot Ulcers (MDT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Forough Pouryazdanpanah Kermani, Kerman Medical University
ClinicalTrials.gov Identifier:
NCT01681160
First received: September 4, 2012
Last updated: September 7, 2012
Last verified: September 2012
  Purpose

This study was a Kind of clinical trial with equal randomization, that have been done from January 2009 to June 2011 in the AFZALIPOOR hospital endocrine ward in Kerman-Iran on 128 diabetic patient who had foot wounds.Replacement of conventional therapy by new methodes is one of the more important aims for health professional specially for nurses.One of this new treatment is maggot therapy.


Condition Intervention
DIABETIC FOOT ULCERS
Other: procedure:maggot therapy
Other: conventional therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Maggot Therapy in Diabetic Foot Ulcers

Resource links provided by NLM:


Further study details as provided by Kerman Medical University:

Primary Outcome Measures:
  • change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 3days and change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 6 days [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Enrollment: 128
Study Start Date: January 2009
Study Completion Date: June 2011
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: MAGGOT THERAPY & conventional therapy T
Maggot therapy,ADMINISTERED TWO TIMES AS A NEW METHODS OF DRESSING in experimental group.conventional therapy ,administered two times in control group
Other: procedure:maggot therapy
each times in maggot therapy continued for three days.wound assessment was done before and after any intervention
Other Name: larval therapy
Other: conventional therapy
patients receive ordinary treatment for diabetic foot
Other Name: mechanical debridement

  Eligibility

Ages Eligible for Study:   40 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Have a chronic illness more than 7 weeks.
  • The age of the patients between 40- 90 years old.
  • Not having capillary disease (Blockage of artery, Rinold).
  • Not user of anticoagulants and corticosteroids drugs.
  • Patients without history of allergy to drugs and foods.
  • Having diabetic type 2

Exclusion Criteria:

  • patients who refer to critical clinical care unit
  • patients who have amputation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Forough Pouryazdanpanah Kermani, university instructor, Kerman Medical University
ClinicalTrials.gov Identifier: NCT01681160     History of Changes
Other Study ID Numbers: 86/116
Study First Received: September 4, 2012
Last Updated: September 7, 2012
Health Authority: Iran: Ministry of Health

Keywords provided by Kerman Medical University:
MAGGOT THERAPY
DIABETIC FOOT
NURSING CARE
DRESSING

Additional relevant MeSH terms:
Ulcer
Foot Ulcer
Diabetic Foot
Pathologic Processes
Foot Diseases
Skin Diseases
Leg Ulcer
Skin Ulcer
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Diabetic Neuropathies

ClinicalTrials.gov processed this record on July 24, 2014